Abstract
Caffeic acid (CA) is a well-known to inhibit thrombogenic thromboxane A2 (TXA2) production, but there are no reports for the supply and usage of its precursor arachidonic acid (AA) and the release of serotonin, another thrombogenic molecule. In this study, we investigated the effect of CA on the phosphorylation of AA supply enzymes [cytosolic phospholipase A2α (cPLA2α), and phospholipase Cγ2 (PLCγ2)] and AA utilization enzymes [cyclooxygenase (COX)-1, TXA2 synthase (TXAS)] in collagen-activated human platelets. p38 MAPK phosphorylation associated with TXA2 production and c-Jun NH2-terminal kinase 1 (JNK1) phosphorylation associated with serotonin release were also determined. CA inhibited collagen-induced TXA2 production in a dose-dependent manner. It acted by counteracting the phosphorylation of AA release enzyme (PLCγ2) and AA utilization enzymes (COX-1 and TXAS) without affecting p38 MAPK and cPLA2α in collagenactivated human platelets. CA decreased collagen-released serotonin by inhibiting JNK1 phosphorylation. Therefore, our data demonstrate that CA might protect TXA2- and serotonin-mediated thrombogenesis.
Similar content being viewed by others
References
Schwartz, S. M., R. L. Heimark, and M. W. Majesky (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70: 1177–1209.
Berridge, M. J. and R. F. Irvine (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315–321.
Jennings, L. K. (2009) Role of Platelets in Atherothrombosis. Am. J. Cardiol. 103: 4A–10A.
Mangin, P., C. Nonne, A. Eckly, P. Ohlmann, M. Freund, B. Nieswandt, J. P. Cazenave, and F. Lanza (2003) A PLC?2–independent platelet collagen aggregation requiring functional aßsociation of GPVI and integrin a2ß1. FEBS Lett. 542: 53–59.
Nishikawa, M., T. Tanaka, and H. Hidaka, (1980) Ca2+–calmodulin–dependent phosphorylation and platelet secretion. Nature 287: 863–865.
Kaibuchi, K., K. Sano, M. Hoshijima, Y. Takai, and Y. Nishizuka (1982) Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium. 3: 323–335.
Kramer, R. M., E. F. Roberts, S. L. Um. A. G. Börsch–Haubold, S. P. Watson, M. J. Fisher, and J. A. Jakubowski (1996) p38 mitogen–activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin–stimulated platelets. J. Biol. Chem. 271: 27723–27729.
Lee, J. S., K. R. Lee, S. Lee, H. J. Lee, H. S. Yang, J. H. Yeo, J. M. Park, B. H. Choi, and E. K. Hong (2017) Polysaccharides isolated from liquid culture broth of Inonotus obliquus inhibit the invasion of human non–small cell lung carcinoma cells. Biotechnol. Bioproc. Eng. 22: 45–51.
Lee, K. S., D. H. Lee, Y. S. Kwon, S. Y. Chun, and K. S. Nam (2014) Deep–sea water inhibits metastatic potential in HT–29 human colorectal adenocarcinomas via MAPK/NF–?B signaling pathway. Biotechnol. Bioproc. Eng. 19: 733–739.
FitzGerald, G. A. (1991) Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am. J. Cardiol. 68: 11B–15B.
Ruggeri, Z. M. (2002) Platelets in atherothrombosis. Nat. Med. 8: 1227–1234.
Armstrong, P. C., N. S. Kirkby, Z. N. Zain, M. Emerson, J. A. Mitchell, and T. D. Warner (2011) Thrombosis is reduced by inhibition of COX–1, but unaffected by inhibition of COX–2, in an acute model of platelet activation in the mouse. PLoS One 6: e20062.
Ichikawa, K., S. Tazawa, S. Hamano, M. Kojima, and S. Hiraku (1999) Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models. Pharmacology 59: 257–265.
Malhotra, S., Y. P. Sharma, A. Grover, S. Majumdar, S. M. Hanif, V. K. Bhargava, A. Bhatnagar, and P. Pandhi (2003) Effect of different aspirin doses on platelet aggregation in patients with stable coronary artery disease. Intern. Med. J. 33: 350–354.
Pulcinelli, F. M., P. Pignatelli, A. Celestini, S. Riondino, P. P. Gazzaniga, and F. Violi (2004) Inhibition of platelet aggregation by aspirin progressively decreases in long–term treated patients. J. Am. Coll. Cardiol. 43: 979–984.
Lee, D. H., H. H. Kim, H. J. Cho, J. S. Bae, Y. B. Yu, and H. J. Park (2014) Antiplatelet effects of caffeic acid due to Ca2+ mobilization–inhibition via cAMP–dependent inositol–1, 4, 5–trisphosphate receptor phosphorylation. J. Atheroscler. Thromb. 21: 23–37.
Lu, Y., Q. Li, Y. Y. Liu, K. Sun, J. Y. Fan, C. S. Wang, and J. Y. Han (2015) Inhibitory effect of caffeic acid on ADP–induced thrombus formation and platelet activation involves mitogenactivated protein kinases. Sci. Rep. 5: 13824.
Kauskot, A., F. Adam, A. Mazharian, N. Ajzenberg, E. Berrou, A. Bonnefoy, J. P. Rosa, M. F. Hoylaerts, and M. Bryckaert (2007) Involvement of the mitogen–activated protein kinase c–Jun NH2–terminal kinase 1 in thrombus formation. J. Biol. Chem 282: 31990–31999.
Adam, F., A. Kauskot, J. P. Rosa, and M. Bryckaert (2008) Mitogen–activated protein kinases in hemostasis and thrombosis. J. Thromb. Haemost. 6: 2007–2016.
Adam, F., A. Kauskot, P. Nurden, E. Sulpice, M. F. Hoylaerts, R. J. Davis, J. P. Rosa, and M. Bryckaert (2010) Platelet JNK1 is involved in secretion and thrombus formation. Blood 115: 4083–4092.
Jackson, E. C. G., G. Ortar, and A. McNicol (2013) The effects of an inhibitor of diglyceride lipase on collagen–induced platelet activation. J. Pharmacol. Exp. Ther. 347: 582–588.
Shin, J. H., H. W. Kwon, M. H. Rhee, and H. J. Park (2018) Inhibitory effects of thromboxane A2 generation by ginsenoside Ro due to attenuation of cytosolic phospholipase A2 phosphorylation and arachidonic acid release. J. Ginseng Res. https://doi.org/10.1016/j.jgr.2017.12.007
Chen, T. G., J. J. Lee, K. H. Lin, C. H. Shen, D. S. Chou, and J. R. Sheu (2007) Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP–dependent pathway in human platelets. Chin. J. Physiol. 50: 121–126.
Park, J. B. (2009) 5–Caffeoylquinic acid and caffeic acid orally administered suppress P–selectin expression on mouse platelets. J. Nutr. Biochem. 20: 800–805.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nam, G.S., Nam, KS. & Park, HJ. Caffeic Acid Diminishes the Production and Release of Thrombogenic Molecules in Human Platelets. Biotechnol Bioproc E 23, 641–648 (2018). https://doi.org/10.1007/s12257-018-0424-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-018-0424-0